B. Duretz

Liquid chromatography high resolution mass spectrometry for the determination of baclofen and its metabolites in plasma: Application to therapeutic drug monitoring.

B. Granger, X. Declèves, L. Labat, 2017, Biomedical chromatography : BMC.

Development of a fully automated toxicological LC-MSn screening system in urine using online extraction with turbulent flow chromatography

K. Rentsch, B. Duretz, D. Mueller, 2011, Analytical and bioanalytical chemistry.

Isotope dilution high-performance liquid chromatography-electrospray tandem mass spectrometry assay for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in biological samples.

J. Cadet, T. Douki, J. Ravanat, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Amatoxins (α- and β-Amanitin) and phallotoxin (Phalloidin) analyses in urines using high-resolution accurate mass LC-MS technology.

I. Morel, T. Gicquel, O. Tribut, 2014, Journal of analytical toxicology.

Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.

A. Hulin, I. Gana, B. Duretz, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology

S. Rudaz, B. Testa, K. Zaman, 2014, Analytical and Bioanalytical Chemistry.

Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry.

Pierre Marquet, Bénédicte Duretz, Franck Saint-Marcoux, 2006, Clinical chemistry.